Whose Values In Adolescent Health- Adults Or Adolescents?

Published Jun 17, 2012
Adelaide, South Australia – Differences between adolescents and adult values for assessing the health benefits of new medical interventions may be significant enough to impact upon health care policy. An on-line survey including two health status instruments, the CHU9D and the AQOL-6D was developed for administration to adolescents living in Australia, aged 11-17 years (n=500). Individual responses to both instruments were converted to values by applying firstly the adult and secondly the adolescent scoring algorithms for each instrument. Both instruments discriminated well according to current health status and the presence of long standing illness regardless of the scoring algorithm employed. Important differences, however, between adolescent and adult values were found, these being more profound for the CHU9D. This study, “Whose Values in Health? An Empirical Comparison of the Application of Adolescent and Adult Values for the CHU9D and AQOL-6D in the Australian Adolescent General Population,” will appear in a future issue of Value in Health, and was co-authored by Julie Ratcliffe from Flinders University, Katherine Stevens and John Brazier from the University of Sheffield, Terry Flynn from the University of Technology Sydney and Michael Sawyer from the University of Adelaide. Says Professor Ratcliffe, “We have utilised a community based sample of adolescents to highlight potentially important differences in adult and adolescent values for identical health states. Ultimately these differences could significantly impact upon the results of studies to assess the cost effectiveness of new medical interventions targeted for adolescents.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

From Promise to Proof: Strengthening the Evidence Base for Digital Health Technologies

Apr 28, 2026

Value in Health announced the publication of a special themed section of research papers that advances evidence and methods for evaluating the real-world value of digital health technologies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×